Nov 12 2026

Iberdrola begins trials to electrify Bayer’s production process in Asturias with 100% renewable steam

261105 bayer iberdrola

The project, which will supply the steam needs of the Bayer plant that produces acetylsalicylic acid for the entire world, involved a total investment of €18 million. The initiative includes a 15 MW renewable energy PPA and will eliminate around 6,500 tonnes of CO₂, positioning the Asturian mining basin as a benchmark for an industrial model moving toward electrification as a pillar of competitiveness.

The Bayer plant in La Felguera (Langreo) has begun receiving 100% renewable steam generated by Iberdrola to produce acetylsalicylic acid. The energy company has electrified the production of this steam, replacing fossil fuels with renewable electricity, which will eliminate 6,500 tonnes of CO₂ per year.

The process uses a thermal salt storage system that stores renewable energy to produce steam at any time of day. This way, during the periods when electricity is most competitive—that is, when there is more renewable generation—it is stored for use whenever the industrial process requires it.

To supply the electricity needed to produce 100% of the steam consumed by the process, Iberdrola has developed a 15 MW renewable energy PPA (Power Purchase Agreement) and a 2.5 MW self-consumption photovoltaic installation.

Furthermore, this is the first large-scale heat electrification project with thermal storage in Spain, structured through a long-term Heat Purchase Agreement (Heat Purchase Agreement). For its implementation, the energy company invested over 18 million euros and involved more than 60 professionals.

The facility, currently in the testing phase, replaces gas consumption and opts for an industrial electrification model to produce, among other active ingredients, acetylsalicylic acid. This is fundamental for moving toward an energy model that is secure, self-sufficient, competitive, and sustainable, independent of fossil fuels. This commitment positions the Asturian mining basin as a benchmark in sustainable development and competitiveness, featuring industrial innovation developed in Spain.

Acetylsalicylic acid, produced in La Felguera, is the active ingredient in Bayer’s well-known Aspirin®, which, along with other active ingredients manufactured at the Asturian facility, is distributed from there worldwide. This commitment bolsters the transformation of a strategic facility for the pharmaceutical company on a global scale. Electrifying the production process will enable Bayer to advance its decarbonization and strengthen—as a cornerstone of competitiveness and industrial resilience—the strategic autonomy of Asturias, Spain, and Europe, while reducing energy dependence.

Original source: Iberdrola

Scroll to Top